Skip to content

Public FDA record

Z-1351-2023: Outset Tablo Model Numbers (REF): PN-0006000 PN-0007001 Tablo is a next generation, self-contained hemo

Recall record Z-1351-2023 for Outset Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1351-2023
Company in FDA record
Outset Medical, Inc.
FDA classification date
Apr 7, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

An observed trend of high conductivity dialysate alarms in a hemodialysis system as a result of introducing a software tool into the manufacturing process.

Source facts

Action
On 01/24/2023, the firm communicated an "MEDICAL DEVICE FIELD ACTION" Letter via FedEx Standard Overnight to customers informing them that Outset Medical has identified that Tablo Hemodialysis Systems manufactured between May 2021 and February 2022 require recalibration of the conductivity sensor, due to the dialysate conductivity sensor giving potentially false trigger alarms such as Alarm_Dialysate_Conductivity_High or Dialysate Conductivity Error. In addition, in devices where recalibration is needed and isolated only to treatments where the prescribed sodium is less than or equal to 133mEq/L, there may be an unlikely occurrence of delivered dialysate sodium falling outside of listed device specifications. In these remote cases, the need for clinical intervention is not expected. Actions to be taken by Customer/user: " Outset Medical has assessed the risk of this issue and customer's Tablo device can continue to be used until serviced. " Outset request that customers complete the enclosed acknowledgment form and promptly return it to Outset Medical. " Disseminate this information to appropriate personnel within the customer's facility for processing and distribution. Actions to be taken by Outset: -Firm will recalibrate the conductivity sensor as part of routine maintenance or at the next service call. An Outset Field Service Engineer will coordinate the completion of the recalibration with your staff to minimize downtime of your Tablo system(s). Any questions, contact Outset Customer Experience team at 844-MYTABLO or 844-698-2256.
Initiated
2023-01-24
Root cause
Process control
Distribution
U.S. Nationwide distribution including in the states of AK, AL, AR, CA, CO, FL, GA, HI, IA, ID, IL, IN, MI, MS, MO, MT, NE, NV, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX, UT, VT, VA, and WI. O.U.S.: Not provided.
Recall number
Z-1351-2023
Recall status
Open, Classified
CDRH record ID
198994
FDA classified
2023-04-07
Recall event number
91844

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗